Nuveen Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $16.4M | Sell |
388,661
-4,099
| -1% | -$172K | ﹤0.01% | 1300 |
|
|
2024
Q3 | $21.8M | Buy |
392,760
+188,537
| +92% | +$10.5M | 0.01% | 1135 |
|
|
2024
Q2 | $8.39M | Sell |
204,223
-159,144
| -44% | -$6.54M | ﹤0.01% | 1689 |
|
|
2024
Q1 | $17M | Sell |
363,367
-94,080
| -21% | -$4.39M | 0.01% | 1277 |
|
|
2023
Q4 | $21.9M | Buy |
457,447
+26,775
| +6% | +$1.28M | 0.01% | 1093 |
|
|
2023
Q3 | $15.4M | Sell |
430,672
-1,018
| -0.2% | -$36.3K | 0.01% | 1205 |
|
|
2023
Q2 | $19.9M | Sell |
431,690
-19,728
| -4% | -$910K | 0.01% | 1064 |
|
|
2023
Q1 | $18.1M | Sell |
451,418
-12,951
| -3% | -$519K | 0.01% | 1110 |
|
|
2022
Q4 | $21.5M | Buy |
464,369
+260,212
| +127% | +$12.1M | 0.01% | 990 |
|
|
2022
Q3 | $8.45M | Buy |
204,157
+3,874
| +2% | +$160K | ﹤0.01% | 1587 |
|
|
2022
Q2 | $11.9M | Sell |
200,283
-57,862
| -22% | -$3.45M | ﹤0.01% | 1397 |
|
|
2022
Q1 | $17.8M | Buy |
258,145
+1,690
| +0.7% | +$116K | 0.01% | 1261 |
|
|
2021
Q4 | $21.6M | Sell |
256,455
-44,070
| -15% | -$3.71M | 0.01% | 1187 |
|
|
2021
Q3 | $27.1M | Buy |
300,525
+13,568
| +5% | +$1.22M | 0.01% | 1060 |
|
|
2021
Q2 | $27.4M | Sell |
286,957
-82,675
| -22% | -$7.88M | 0.01% | 1132 |
|
|
2021
Q1 | $42.1M | Sell |
369,632
-28,791
| -7% | -$3.28M | 0.01% | 813 |
|
|
2020
Q4 | $55.2M | Buy |
398,423
+14,017
| +4% | +$1.94M | 0.02% | 647 |
|
|
2020
Q3 | $31.6M | Sell |
384,406
-50,157
| -12% | -$4.12M | 0.01% | 798 |
|
|
2020
Q2 | $34M | Buy |
434,563
+103,472
| +31% | +$8.09M | 0.01% | 723 |
|
|
2020
Q1 | $14.7M | Buy |
331,091
+28,322
| +9% | +$1.26M | 0.01% | 1066 |
|
|
2019
Q4 | $12.9M | Buy |
302,769
+29,383
| +11% | +$1.25M | ﹤0.01% | 1435 |
|
|
2019
Q3 | $11.7M | Sell |
273,386
-1,695
| -0.6% | -$72.5K | ﹤0.01% | 1466 |
|
|
2019
Q2 | $17.5M | Buy |
275,081
+270,742
| +6,240% | +$17.2M | 0.01% | 1237 |
|
|
2019
Q1 | $301K | Buy |
+4,339
| New | +$301K | ﹤0.01% | 933 |
|
|
2017
Q3 | – | Sell |
-19,439
| Closed | -$1.21M | – | 1128 |
|
|
2017
Q2 | $1.21M | Buy |
19,439
+8,090
| +71% | +$502K | 0.01% | 710 |
|
|
2017
Q1 | $769K | Sell |
11,349
-3,368
| -23% | -$228K | ﹤0.01% | 1050 |
|
|
2016
Q4 | $1.04M | Sell |
14,717
-6,066
| -29% | -$427K | 0.01% | 1130 |
|
|
2016
Q3 | $1.47M | Sell |
20,783
-1,896
| -8% | -$134K | 0.01% | 907 |
|
|
2016
Q2 | $1.11M | Buy |
22,679
+5,331
| +31% | +$261K | 0.01% | 985 |
|
|
2016
Q1 | $1.1K | Sell |
17,348
-3,233
| -16% | -$205 | 0.01% | 980 |
|
|
2015
Q4 | $2.31K | Sell |
20,581
-1,133
| -5% | -$127 | 0.01% | 712 |
|
|
2015
Q3 | $2.09K | Buy |
21,714
+554
| +3% | +$53 | 0.01% | 735 |
|
|
2015
Q2 | $2.17K | Buy |
+21,160
| New | +$2.17K | 0.01% | 782 |
|